Cell Robotics' CEO Interviewed by WallStreetReporter.com About Diabetic Laser.Health/Medical Writers Albuquerque, N.M.--(BW HealthWire)--April 4, 2000 Cell Robotics International Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). : CRII CRII Cooperative Research in Information Infrastructure CRII Customer Returns Improvement Initiative ), the developer of the Personal Lasette(R), a laser finger perforator per·fo·rate v. per·fo·rat·ed, per·fo·rat·ing, per·fo·rates v.tr. 1. To pierce, punch, or bore a hole or holes in; penetrate. 2. that allows the drawing of capillary blood in a nearly painless manner, today announced that Dr. Ronald K. Lohrding, Cell Robotics' president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , was interviewed by WallStreetReporter.com. The interview is now available on the Web site at http://www.wallstreetreporter.com/. WallStreetReporter is an online information source for professional investors seeking successful new investment ideas. Each day they interview CEO's of leading public companies that are making important news. The site's in-depth interviews are geared towards sophisticated investors who demand an unbiased, unscripted un·script·ed adj. Not adhering to or in accordance with a script written beforehand: "his unscripted encounters with the press" Eleanor Clift. , first-hand perspective that enables them to make informed investment decisions. In December 1996, WallStreetReporter became the first Internet site to feature daily CEO interviews. Their interviews have been heard by more than two million investors worldwide. The site also publishes a complementary monthly publication: Wall Street Reporter Magazine, which is read by more than 25,000 stockbrokers, portfolio managers, analysts and sophisticated investors. About Cell Robotics International Cell Robotics International Inc. is a medical products company committed to enhancing the quality of life through technology. CRII manufactures, markets and distributes the Lasette(TM), the only FDA-cleared alternative to the needle or steel blade lancet currently available for diabetics to draw blood so as to test their glucose levels. The company's additional products include its IVF IVF in vitro fertilization. IVF abbr. in vitro fertilization IVF 1 In vitro fertilization, see there 2. Intravascular fluid Workstation (TM), a state-of-the-art infertility treatment and the Cell Robotics Workstation(TM), an innovative scientific research instrument that uses laser light to transform a microscope from a viewing device into a tool for physically manipulating and dissecting dis·sect tr.v. dis·sect·ed, dis·sect·ing, dis·sects 1. To cut apart or separate (tissue), especially for anatomical study. 2. living cells in microspace. Additional information on all Cell Robotics' products is available on the company's Web Site at http://www.cellrobotics.com, by e-mail at crii@cellrobotics.com, or by telephone at 505/343-1131. As a cautionary note to investors, certain matters discussed in this news release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the company's ability to execute its service and product sales plans; and the risks described from time to time in the company's Securities and Exchange Commission filings. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion